What is the level of liabilities of Diaceutics this year?
Diaceutics has a debt balance of 3.75 M GBP this year.
Diaceutics Liabilities 2024
Diaceutics Liabilities
3.75 M GBP
Ticker
DXRX.L
ISIN
GB00BJQTGV64
WKN
A2PF80
In 2024, Diaceutics's total liabilities amounted to 3.75 M GBP, a -34.71% difference from the 5.74 M GBP total liabilities in the previous year.
Diaceutics Aktienanalyse
What does Diaceutics do?
Diaceutics PLC is a consulting company specializing in optimizing diagnostic and treatment solutions for patients with serious and complex diseases. It was founded in 2005 by Peter Keeling in Belfast, Northern Ireland, and is now headquartered in London, UK. The company is listed on the London Stock Exchange and has offices in Europe, Asia, North America, and Australia. The business model of Diaceutics is based on the increasing number of personalized medicines on the market, targeting specific genetic markers to enable more accurate diagnosis and treatment. The company specializes in analyzing laboratory data to help doctors and pharmaceutical companies identify the specific tests needed for treating individual patients. It also offers a variety of services to optimize the use of tests in patient care. Diaceutics operates in three divisions: Diagnostic Services, Data and Analytics Services, and Strategy and Implementation Services. Diagnostic Services include optimizing diagnostic tests and identifying patient populations that would benefit from a particular treatment. Data and Analytics Services involve setting up data and analytics platforms to gain insights into the use of diagnostic tests in clinical practice. Strategy and Implementation Services support pharmaceutical companies in conducting campaigns to promote the use of diagnostic tests and increase the availability of personalized medicines. Diaceutics' products and services also include Diagnostic Insights products, providing insights into the use of diagnostic tests in various therapy areas. These insights help pharmaceutical companies optimize their personalization strategies and enhance the effectiveness of their medicines. The company also offers diagnostic programs aimed at promoting the use of diagnostic tests in clinical practice and eliminating barriers to the use of personalized medicines. Diaceutics has established partnerships with many of the world's leading diagnostic and pharmaceutical companies and also provides consulting services to support them in developing personalization strategies. Its clients include both pharmaceutical and diagnostic companies. Overall, Diaceutics has become a leading provider of personalized healthcare solutions. It occupies a unique position in the market by focusing on the intersection of diagnostics and therapy and being able to offer a wide range of products and services. Given the rapid progress in personalized medicine, Diaceutics will continue to play a significant role in optimizing diagnosis and treatment strategies and providing better care for patients. Diaceutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Diaceutics's Liabilities
Diaceutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Diaceutics's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Diaceutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Diaceutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Diaceutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Diaceutics stock
What were the liabilities of Diaceutics compared to the previous year?
The liabilities of Diaceutics have increased by -34.71% dropped compared to the previous year.
What are the consequences of high debt for investors of Diaceutics?
High liabilities can pose a risk for investors of Diaceutics, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Diaceutics?
Low liabilities mean that Diaceutics has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Diaceutics affect the company?
An increase in liabilities of Diaceutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Diaceutics affect the company?
A decrease in the liabilities of Diaceutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Diaceutics?
Some factors that can influence the liabilities of Diaceutics include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Diaceutics so important for investors?
The liabilities of Diaceutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Diaceutics take to modify the liabilities?
To change its liabilities, Diaceutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Diaceutics pay?
Over the past 12 months, Diaceutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Diaceutics is expected to pay a dividend of 0 GBP.
What is the dividend yield of Diaceutics?
The current dividend yield of Diaceutics is .
When does Diaceutics pay dividends?
Diaceutics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Diaceutics?
Diaceutics paid dividends every year for the past 0 years.
What is the dividend of Diaceutics?
For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.
In which sector is Diaceutics located?
Diaceutics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Diaceutics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Diaceutics from 9/8/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 9/8/2024.
When did Diaceutics pay the last dividend?
The last dividend was paid out on 9/8/2024.
What was the dividend of Diaceutics in the year 2023?
In the year 2023, Diaceutics distributed 0 GBP as dividends.
In which currency does Diaceutics pay out the dividend?
The dividends of Diaceutics are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Diaceutics
Our stock analysis for Diaceutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Diaceutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
